Clinical trial
Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects (HS rPMS)
The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Expected enrolment | 600 |
| Study start date | 2017-02-01 |
| Estimated primary completion date | 2019-03-01 |